masld

Documents about masld

• Food Insecurity and MASLD: A Fruit and Vegetable Intervention Study#875568ClinicalTrials.gov
• Effect of Tirzepatide on Markers of MASLD in Patients With Obesity#918141ClinicalTrials.gov
• Study of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults With Type 1 Diabetes#915516ClinicalTrials.gov
• SMART Diets for MASLD#917212ClinicalTrials.gov
• Effects of Normobaric Hypoxic Training in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)#651160ClinicalTrials.gov
• Nutritional Education Program for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)#861205ClinicalTrials.gov
• Integrating Hepatological, Nutritional, and Psychological Support as a Multidisciplinary Management to Improve Long-term Clinical Outcomes in MASLD#801986ClinicalTrials.gov
• The Effect of the DASH Diet on Clinical and Metabolic Parameters in Children With MASLD#268097ClinicalTrials.gov
• The relationship between chronic intermittent hypoxia and masld and fibrosis in obstructive sleep apnea patients#305635Recep Tayyip Erdoğan University Institutional Repository
• A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD#884891ClinicalTrials.gov
• Pediatric Metabolic Dysfunction-associated Steatotic Liver Disease and Food Insecurity#891137ClinicalTrials.gov
• MASLD as Complication of Diabetes.#388783NCBI PubMed Central
• The Effects of Dihydromiricetin on MASLD#633847ClinicalTrials.gov
• Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults MASLD Patients (DELI_MASLD Study)#369969ClinicalTrials.gov
• Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD#321613ClinicalTrials.gov
• A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV#906493ClinicalTrials.gov
• Denominator bias in MENA MASLD epidemiology: A call for decision-grade surveillance#455661Recep Tayyip Erdoğan University Institutional Repository
• Thermoacoustic Method for Estimating Liver Fat Fraction#991699ClinicalTrials.gov
• Machine Learning Prediction of Liver Fibrosis in Patients with Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)#433288HAL (France)
• Supplementary material: IMCL:EMCL ratio relates to insulin resistance and impaired substrate metabolism in MASLD#1002239University of Nottingham Repository
• Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study#203167Recep Tayyip Erdoğan University Institutional Repository
• The Development of MASLD Among Survivors of Breast or Colorectal Cancer#343833ClinicalTrials.gov
• Identification and Characterization of At-risk MASLD in Turkish Adults#143754ClinicalTrials.gov
• Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study#362535Recep Tayyip Erdoğan University Institutional Repository
• Incretins and MASLD: at the Crossroads of Endocrine and Hepatic Disorders#257405HAL (France)
• Disrupted Mitochondrial Copper Homeostasis Promotes Ferroptotic Stress, Senescence and MASLD Progression#373542bioRxiv / medRxiv
• Nutrition in Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).#469015NCBI PubMed Central
• Psychosocial aspects and mental health burden of pediatric MASLD.#678182NCBI PubMed Central
• Cognitive dysfunction in MASLD is linked to platelet activation.#975622NCBI PubMed Central
• Breath volatile profiling reveals a diagnostic signature of MASLD in children#310934bioRxiv / medRxiv
• Flavonoids in MASLD: preclinical mechanisms, pharmacological targets, and translational challenges.#439111NCBI PubMed Central
• Modelling the impact of physical activity on MASLD in Saudi Arabia.#975745NCBI PubMed Central
• The role of lipid-derived indices in patients with MASLD in Turkey: a nationwide, multicenter cross-sectional study#315277Muğla Sıtkı Koçman University Institutional Repository
• A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)#889606ClinicalTrials.gov
• Integrated Ultrasound-Derived Fat Fraction and 2D/4D HeartAI for Cardiovascular Risk Management in Patients With MASLD#833705ClinicalTrials.gov
• Efficacy and Safety of Rifaximin-α in Treating MASLD#152453ClinicalTrials.gov
• Diagnosing and defining MASLD in people living with chronic hepatitis B.#170574NCBI PubMed Central
• Nanotherapeutic Strategies for MASLD: From Pathological Mechanisms to Targeted Delivery Systems.#666147NCBI PubMed Central
• Alcohol-driven phenotypic transition in MASLD and risk of liver-related events.#295486NCBI PubMed Central
• Call to action-Pediatric MASLD requires immediate attention to curb health crisis.#305423NCBI PubMed Central
• Factors Influencing the MASLD Risk in Type 2 Diabetes: A cross-sectional study#328045Scholar Commons
• A data-driven framework reconstructs the molecular continuum of human MASLD progression.#404476NCBI PubMed Central
• Metabolic Health: The Interplay Between NAFLD, MAFLD, MASLD, and Cardiovascular Disease.#409239NCBI PubMed Central
• Gut Microbiota Alterations and Microbiota-Derived Indole-3-Carboxaldehyde Are Associated with MASLD#677258IBISS
• Palmatine ameliorates MASLD in type 2 diabetes by modulating hepatic apoptosis and inflammation.#25634NCBI PubMed Central
• Sex-specific lipid-mediated mechanisms drive MASLD progression revealed by paired liver-blood multi-omics#192368bioRxiv / medRxiv
• Circadian and behavioral timing in MASLD: a systematic review of human observational studies.#662906NCBI PubMed Central
• Long-term mortality and extrahepatic outcomes in 1096 children with MASLD: A retrospective cohort study.#122827NCBI PubMed Central
• Plasma-targeted proteomic and lipidomic profiling of MASLD, MASH, and hepatitis C virus infection.#193728NCBI PubMed Central
• Steatotic liver disease trajectory: A holistic EASL guidance on the multidisciplinary approach to screening and patient management#624791HAL (France)